If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
248
|
115
|
591
|
97
|
51
|
3
|
1088
|
Gene and significance breakdown #
Total genes and gene combinations: 63
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
CEP290
|
64
|
13
|
273
|
30
|
24
|
0 |
401
|
CRB1
|
30
|
12
|
99
|
28
|
8
|
0 |
176
|
RPE65
|
34
|
21
|
46
|
9
|
9
|
0 |
112
|
GPHN, RDH12
|
17
|
6
|
29
|
8
|
2
|
0 |
61
|
LCA5
|
7
|
2
|
26
|
7
|
4
|
2
|
47
|
LRAT
|
0 |
3
|
26
|
5
|
0 |
0 |
34
|
AIPL1
|
8
|
3
|
13
|
3
|
0 |
0 |
27
|
RPGRIP1
|
18
|
7
|
1
|
0 |
0 |
0 |
25
|
GPHN, RDH12, ZFYVE26
|
5
|
4
|
15
|
1
|
0 |
0 |
24
|
GUCY2D
|
5
|
15
|
1
|
0 |
0 |
0 |
21
|
RD3
|
0 |
0 |
17
|
1
|
1
|
0 |
19
|
CEP290, RLIG1
|
3
|
0 |
11
|
1
|
0 |
0 |
15
|
TULP1
|
10
|
1
|
1
|
1
|
0 |
0 |
13
|
SPATA7
|
6
|
6
|
0 |
0 |
0 |
0 |
12
|
CRX
|
2
|
1
|
4
|
1
|
3
|
0 |
11
|
NMNAT1
|
4
|
5
|
0 |
0 |
0 |
0 |
8
|
USH2A
|
0 |
1
|
6
|
0 |
0 |
0 |
7
|
ALMS1
|
3
|
3
|
0 |
0 |
0 |
0 |
6
|
IQCB1
|
5
|
2
|
0 |
0 |
0 |
0 |
6
|
CEP290, LOC129390514
|
2
|
0 |
3
|
0 |
0 |
0 |
5
|
GIGYF2, KCNJ13
|
1
|
0 |
3
|
1
|
0 |
0 |
5
|
CNGB3
|
3
|
0 |
0 |
0 |
0 |
0 |
3
|
LOC130056226, SPATA7
|
1
|
2
|
0 |
0 |
0 |
0 |
3
|
RP2
|
2
|
1
|
0 |
0 |
0 |
0 |
3
|
ADAMTS18, LOC126862407
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
AHI1
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
CCT2
|
0 |
2
|
0 |
0 |
0 |
0 |
2
|
NPHP4
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
PROM1
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
ABCA4
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
ABCA4, LOC126805793
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
BBS1, ZDHHC24
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
CC2D2A
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
CDHR1
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
CFAP410
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
CLUAP1
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
COPB2-DT, RBP1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
FSCN2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
GRM6
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
GRM6, ZNF454
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
GUCA1B
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
IFT140
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
IFT140, LOC126862260
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
IMPDH1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
IMPDH1, LOC107986845
|
0 |
0 |
0 |
1
|
0 |
0 |
1
|
INPP5E
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
LOC122152296, USH2A
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
LOC126806932, PCYT1A
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
LRP5
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NPHP1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NPHP3, NPHP3-ACAD11
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NR2E3
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
OTX2
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
PANK2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
PDE6A
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
PDE6B
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
PEX1
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
PRPF31
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
RGS9
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
RIMS1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
RPGRIP1L
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
SLC38A8
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
WDR19
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
Natera, Inc.
|
117
|
26
|
486
|
82
|
45
|
0 |
756
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
78
|
15
|
7
|
0 |
100
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
41
|
29
|
0 |
0 |
0 |
0 |
70
|
Sharon lab, Hadassah-Hebrew University Medical Center
|
29
|
7
|
0 |
0 |
0 |
0 |
36
|
Institute of Vision Research, Yonsei University College of Medicine
|
17
|
11
|
0 |
0 |
0 |
0 |
28
|
NIHR Bioresource Rare Diseases, University of Cambridge
|
8
|
16
|
0 |
0 |
0 |
0 |
24
|
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
|
10
|
8
|
5
|
0 |
0 |
0 |
23
|
Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel
|
13
|
3
|
2
|
0 |
0 |
0 |
18
|
Rui Chen Lab, Baylor College of Medicine
|
15
|
2
|
0 |
0 |
0 |
0 |
17
|
Molecular Genetics Laboratory, Institute for Ophthalmic Research
|
14
|
0 |
0 |
0 |
0 |
0 |
14
|
Cytogenetics and Genomics Laboratory, Medical University of South Carolina
|
2
|
5
|
6
|
0 |
0 |
0 |
13
|
Molecular Diagnostics Laboratory, Seoul National University Hospital
|
0 |
0 |
12
|
0 |
0 |
0 |
12
|
DBGen Ocular Genomics
|
6
|
4
|
2
|
0 |
0 |
0 |
12
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
4
|
2
|
0 |
0 |
0 |
0 |
6
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
|
5
|
0 |
1
|
0 |
0 |
0 |
6
|
Center of Genomic medicine, Geneva, University Hospital of Geneva
|
2
|
0 |
0 |
0 |
0 |
0 |
2
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
2
|
2
|
Division of Molecular and Cellular Biology, National Hospital Organization Tokyo Medical Center
|
0 |
2
|
0 |
0 |
0 |
0 |
2
|
ClinVar Staff, National Center for Biotechnology Information (NCBI)
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Centre for Genomic Medicine, Manchester, Central Manchester University Hospitals
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.